BioCardia (BCDA) Total Current Liabilities (2015 - 2026)

BioCardia (BCDA) has reported Total Current Liabilities for 12 consecutive years, with $2.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Current Liabilities fell 43.57% year-over-year to $2.1 million in Q2 2026; TTM through Jun 2026 was $2.1 million, a 43.57% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, up 4.78% from the prior year.
• Total Current Liabilities was $2.1 million for Q2 2026 at BioCardia, down from $2.8 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $4.1 million in Q1 2024 and troughed at $2.1 million in Q2 2026.
• A 5-year average of $3.3 million and a median of $3.5 million in 2022 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities increased 18.4% in 2023 and plunged 43.57% in 2026, its largest moves.
• Over 5 years, Total Current Liabilities stood at $3.6 million in 2022, then climbed by 0.64% to $3.6 million in 2023, then plunged by 35.67% to $2.3 million in 2024, then advanced by 4.78% to $2.4 million in 2025, then fell by 15.5% to $2.1 million in 2026.
• The last three Total Current Liabilities figures came in at $2.1 million (Q2 2026), $2.8 million (Q1 2026), and $2.4 million (Q4 2025), per Business Quant data.